Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0360220170580030296
Journal of the Korean Ophthalmological Society
2017 Volume.58 No. 3 p.296 ~ p.304
Comparison of Choroidal Thickness Change between Ranibizumab and Aflibercept in Age-related Macular Degeneration: Six Month Results
Kim Im-Gyu

Kim Yong-Il
Kim Jin-Seon
Lee Jung-Ho
Lee Kyoo-Won
Kang Hyun-Gu
Abstract
Purpose: To compare the changes in subfoveal choroidal thickness between intravitreal aflibercept and ranibizumab injection in wet age-related macular degeneration (AMD).

Methods: Fifty patients with wet AMD patients who were treated with aflibercpet or ranibizumab were evaluated retrospectively. All patients were treated with pro re nata after 3 consecutive monthly injections and were followed up for at least 6 months. We measured subfoveal choroidal thickness (SFCT) using enhanced depth imaging spectral-domain optical coherence tomography before the first injection and 1, 2, 3, and 6 months after initial injection.

Results: The SFCT measures before initial injection and 1, 2, 3, and 6 months after initial injection were 244.94 ¡¾ 103.77 ¥ìm, 219.04 ¡¾ 95.89 ¥ìm, 208.74 ¡¾ 91.03 ¥ìm, 203.64 ¡¾ 91.35 ¥ìm, and 226.98 ¡¾ 96.79 ¥ìm in the aflibercept group (25 eyes) and 222.68 ¡¾ 102.04 ¥ìm, 210.23 ¡¾ 95.91 ¥ìm, 203.66 ¡¾ 99.39 ¥ìm, 197.27 ¡¾ 100.25 ¥ìm, and 210.32 ¡¾ 111.86 ¥ìm in the ranibizumab group (28 eyes). Mean change in SFCT was greater in the aflibercept group at 1 month, 2 months, and 3 months after initial injection (p < 0.05), but there was no significant difference in the mean change in SFCT between the two groups at 6 months after initial injection (p > 0.05).

Conclusions: The decrease in SFCT was greater after aflibercept injection than ranibizumab injection in 3 consecutive months. However, at 6 months after initial injection, the difference in the change in SFCT was not significant.
KEYWORD
Aflibercept, Polypoidal choroidal vasculopathy, Ranibizumab, Subfoveal choroidal thickness, Wet age-related macular degeneration
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø